SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION -- Ignore unavailable to you. Want to Upgrade?

To: DAN LITTLE who wrote (386)6/11/1998 9:23:00 PM
From: OLD JAKE JUSTUS  Read Replies (1) | Respond to of 4891
 
An excellent provider of information asked me to post his message here:

Subject: Re: JAMA DATABASE
Date: 6/11/98 8:12 PM Eastern Daylight Time
From: <A HREF="aol://3548: Milk Man
Message-id: <1998061200121100.UAA21718@ladder01.news.aol.com>

Hi All! Well, I hope you all enjoyed the reading of my 2 earlier posts, now I have a question for any and all: "If Reticulose was not FOR REAL would JAMA store B.S. LIES, about Reticulose, in their DATABANKS?" I Really do think NOT!!

ADVR's only MILKMan.....GOT MILK !!!

GO, GO ADVR!



To: DAN LITTLE who wrote (386)6/11/1998 9:36:00 PM
From: OLD JAKE JUSTUS  Respond to of 4891
 
There are laws throughout the world that are naturally applicable to the country where experimental drugs are going to be used. It is my understanding that Argentina has a law that all experimental drugs that is or will be used in that country, must have been manufactured within that country. Thus, it is necessary to have a manufacturing facility within that country, because the drug is being used there. That is a law. At least that is my understanding.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News